EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement

StatusActive, Not Recruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later May 31, 2026 → May 31, 2028
See other at-risk trials from M.D. Anderson Cancer Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from May 31, 2026 to May 31, 2028
    • Eligibility criteria expanded, about 8 words
    • Study description revised
  2. Primary and study completion dates: Mar 31, 2026 to May 31, 2026v13
  3. Trial status: Recruiting to Active, Not Recruiting
    • Primary and study completion dates: Jan 31, 2026 to Mar 31, 2026
    • Site details revised
    v12
  4. 5 versions Re-verified since Sep 22, 2023, no change to tracked fieldsv7-v11
  5. Primary and study completion dates: Apr 1, 2023 to Jan 31, 2026v6
Show 4 earlier versionsHide 4 earlier versions
  1. Eligibility criteria shortened, about 15 wordsv5
  2. 2 versions Re-verified since Sep 21, 2021, no change to tracked fieldsv3-v4
  3. Study description expanded, about 5 wordsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This phase II trial investigates the effect of EXPAREL compared to lidocane as a local anesthetic in patients who are undergoing pleuroscopy with pleural biopsy and indwelling pleural catheter placement. This trial aims to see whether EXPAREL or lidocane is able to make patients more comfortable.
Trial Details
NCT Number NCT05044468
Lead Sponsor M.D. Anderson Cancer Center
Conditions
(from sponsor)		 Malignant Pleural Neoplasm
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov